Overview

Gender

male

Investor Type

Investment Partner

Alex Mayweg, Ph.D., is founding CSO at Black Diamond. Alex is an accomplished leader in pharmaceutical drug discovery and medicinal chemistry across Europe, the U.S. and Asia. Most recently, Alex served as VP and global head of chemistry at Roche. Alex brings deep operating capabilities, having managed both large research portfolios and successful therapeutic programs. Prior to Roche, Alex earned a Ph.D. in organic chemistry at Oxford University, followed by post-doctorate training at Stanford University. His undergraduate degree was in chemistry from the Imperial College of Science and Technology in London.

Alex joined Versant in 2016 from Roche where he served as VP and global head of chemistry. He brings to Black Diamond deep operating capabilities, having led both large research portfolios and several successful therapeutics programs within Roche.